Adenovirus 36 and obesity: An overview

Viruses

Volumn 7, Issue 7, 2015, Pages 3719-3740

  Ponterio, Eleonora ^a   Gnessi, Lucio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Adv36; Human virus; Immune response; Obesity

Indexed keywords

LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NORADRENALIN; VIRUS PROTEIN;

ADENOVIRUS INFECTION; BIOINFORMATICS; BODY MASS; CELL DIFFERENTIATION; CELL PROLIFERATION; DNA REPLICATION; FLOW CYTOMETRY; GLUCOSE TRANSPORT; IMMUNE RESPONSE; NONHUMAN; OBESITY; PREVALENCE; REVIEW; RISK FACTOR; UPREGULATION; VIRUS INFECTION; ADENOVIRIDAE; ANIMAL; GENETICS; HUMAN; HUMAN ADENOVIRUS INFECTION; ISOLATION AND PURIFICATION; PHYSIOLOGY; VIROLOGY;

ADENOVIRIDAE; ANIMALIA;

ADENOVIRIDAE; ADENOVIRUS INFECTIONS, HUMAN; ANIMALS; HUMANS; OBESITY;

EID: 84936952079     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v7072787     Document Type: Review

References (105)

1. Ng, M.; Fleming, T.; Robinson, M.; Thomson, B.; Graetz, N.; Margono, C.; Mullany, E.C.; Biryukov, S.; Abbafati, C.; Abera, S.F.; et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: A systematic analysis for the global burden of disease study 2013. Lancet 2014, 384, 766–781.
2. WHO. Obesity and overweight. Available online: http://www.who.int/mediacentre/factsheets/fs311/ en/ (accessed on 5 June 2015).
3. Bray, G.A.; Bellanger, T. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine 2006, 29, 109–117.
4. Hill, J.O.; Peters, J.C. Environmental contributions to the obesity epidemic. Science 1998, 280, 1371–1374.
5. Karlsson, E.A.; Beck, M.A. The burden of obesity on infectious disease. Exp. Biol. Med. 2010, 235, 1412–1424.
6. Koenig, S.M. Pulmonary complications of obesity. Am. J. Med. Sci. 2001, 321, 249–279.
7. Jubber, A.S. Respiratory complications of obesity. Int. J. Clin. Pract. 2004, 58, 573–580.
8. Campitelli, M.A.; Rosella, L.C.; Kwong, J.C. The association between obesity and outpatient visits for acute respiratory infections in ontario, Canada. Int. J. Obes. 2014, 38, 113–119.
9. Mullen, J.T.; Moorman, D.W.; Davenport, D.L. The obesity paradox: Body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann. Surg. 2009, 250, 166–172.
10. Calle, E.E.; Thun, M.J.; Petrelli, J.M.; Rodriguez, C.; Heath, C.W., Jr. Body-mass index and mortality in a prospective cohort of U.S. Adults. N. Engl. J. Med. 1999, 341, 1097–1105.
11. Choban, P.S.; Flancbaum, L. The impact of obesity on surgical outcomes: A review. J. Am. Coll. Surg. 1997, 185, 593–603.
12. Arslan, E.; Atilgan, H.; Yavasoglu, I. The prevalence of helicobacter pylori in obese subjects. Eur. J. Intern. Med. 2009, 20, 695–697.
13. Uberos, J.; Molina-Carballo, A.; Fernandez-Puentes, V.; Rodriguez-Belmonte, R.; Munoz-Hoyos, A. Overweight and obesity as risk factors for the asymptomatic carrier state of neisseria meningitidis among a paediatric population. Eur. J. Clin. Microbiol. Infect. Dis. 2010, 29, 333–334.
14. Morgan, O.W.; Bramley, A.; Fowlkes, A.; Freedman, D.S.; Taylor, T.H.; Gargiullo, P.; Belay, B.; Jain, S.; Cox, C.; Kamimoto, L.; et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza a(h1n1) disease. PLoS ONE 2010, 5, e9694.
15. Hegde, V.; Dhurandhar, N.V. Microbes and obesity—Interrelationship between infection, adipose tissue and the immune system. Clin. Microbiol. Infect. 2013, 19, 314–320.
16. Huttunen, R.; Syrjanen, J. Obesity and the risk and outcome of infection. Int. J. Obes. 2013, 37, 333–340.
17. Verlaeten, O.; Griffond, B.; Khuth, S.T.; Giraudon, P.; Akaoka, H.; Belin, M.F.; Fellmann, D.; Bernard, A. Down regulation of melanin concentrating hormone in virally induced obesity. Mol. Cell. Endocrinol. 2001, 181, 207–219.
18. Pasarica, M.; Dhurandhar, N.V. Infectobesity: Obesity of infectious origin. Adv. Food Nutr. Res. 2007, 52, 61–102.
19. Mitra, A.K.; Clarke, K. Viral obesity: Fact or fiction? Obes. Rev. 2010, 11, 289–296.
20. Lyons, M.J.; Faust, I.M.; Hemmes, R.B.; Buskirk, D.R.; Hirsch, J.; Zabriskie, J.B. A virally induced obesity syndrome in mice. Science 1982, 216, 82–85.
21. Carter, J.K.; Ow, C.L.; Smith, R.E. Rous-associated virus type 7 induces a syndrome in chickens characterized by stunting and obesity. Infect. Immun. 1983, 39, 410–422.
22. Dhurandhar, N.V. Is obesity caused by an adenovirus? Expert Rev. Anti-Infect. Ther. 2012, 10, 521–524.
23. Swenson, P.D.; Lowens, M.S.; Celum, C.L.; Hierholzer, J.C. Adenovirus types 2, 8, and 37 associated with genital infections in patients attending a sexually transmitted disease clinic. J. Clin. Microbiol. 1995, 33, 2728–2731.
24. Dhurandhar, N.V. A framework for identification of infections that contribute to human obesity. Lancet Infect. Dis. 2011, 11, 963–969.
25. Dhurandhar, N.V. Insulin sparing action of adenovirus 36 and its e4orf1 protein. J. Diabetes Complicat. 2013, 27, 191–199.
26. Dhurandhar, E.J.; Dubuisson, O.; Mashtalir, N.; Krishnapuram, R.; Hegde, V.; Dhurandhar, N.V. E4orf1: A novel ligand that improves glucose disposal in cell culture. PLoS ONE 2011, 6, e23394.
27. Rathod, M.A.; Rogers, P.M.; Vangipuram, S.D.; McAllister, E.J.; Dhurandhar, N.V. Adipogenic cascade can be induced without adipogenic media by a human adenovirus. Obesity 2009, 17, 657–664.
28. Dhurandhar, N.V.; Kulkarni, P.; Ajinkya, S.M.; Sherikar, A. Effect of adenovirus infection on adiposity in chicken. Vet. Microbiol. 1992, 31, 101–107.
29. Dhurandhar, N.V.; Kulkarni, P.R.; Ajinkya, S.M.; Sherikar, A.A.; Atkinson, R.L. Association of adenovirus infection with human obesity. Obes. Res. 1997, 5, 464–469.
30. Dhurandhar, N.V.; Israel, B.A.; Kolesar, J.M.; Mayhew, G.F.; Cook, M.E.; Atkinson, R.L. Increased adiposity in animals due to a human virus. Int. J. Obes. Relat. Metab. Disord. 2000, 24, 989–996.
31. Whigham, L.D.; Israel, B.A.; Atkinson, R.L. Adipogenic potential of multiple human adenoviruses in vivo and in vitro in animals. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 290, R190–R194.
32. Dhurandhar, N.V. Infectobesity: Obesity of infectious origin. J. Nutr. 2001, 131, 2794S–2797S.
33. Dhurandhar, N.V.; Whigham, L.D.; Abbott, D.H.; Schultz-Darken, N.J.; Israel, B.A.; Bradley, S.M.; Kemnitz, J.W.; Allison, D.B.; Atkinson, R.L. Human adenovirus ad-36 promotes weight gain in male rhesus and marmoset monkeys. J. Nutr. 2002, 132, 3155–3160.
34. Pasarica, M.; Shin, A.C.; Yu, M.; Ou Yang, H.M.; Rathod, M.; Jen, K.L.; MohanKumar, S.; MohanKumar, P.S.; Markward, N.; Dhurandhar, N.V. Human adenovirus 36 induces adiposity, increases insulin sensitivity, and alters hypothalamic monoamines in rats. Obesity 2006, 14, 1905–1913.
35. Dhurandhar, N.V.; Israel, B.A.; Kolesar, J.M.; Mayhew, G.; Cook, M.E.; Atkinson, R.L. Transmissibility of adenovirus-induced adiposity in a chicken model. Int. J. Obes. Relat. Metab. Disord. 2001, 25, 990–996.
36. Kapila, M.; Khosla, P.; Dhurandhar, N.V. Novel short-term effects of adenovirus ad-36 on hamster lipoproteins. Int. J. Obes. Relat. Metab. Disord. 2004, 28, 1521–1527.
37. Pasarica, M.; Loiler, S.; Dhurandhar, N.V. Acute effect of infection by adipogenic human adenovirus ad36. Arch. Virol. 2008, 153, 2097–2102.
38. Vangipuram, S.D.; Sheele, J.; Atkinson, R.L.; Holland, T.C.; Dhurandhar, N.V. A human adenovirus enhances preadipocyte differentiation. Obes. Res. 2004, 12, 770–777.
39. Rathod, M.; Vangipuram, S.D.; Krishnan, B.; Heydari, A.R.; Holland, T.C.; Dhurandhar, N.V. Viral mrna expression but not DNA replication is required for lipogenic effect of human adenovirus ad-36 in preadipocytes. Int. J. Obes. 2007, 31, 78–86.
40. Arnold, J.; Janoska, M.; Kajon, A.E.; Metzgar, D.; Hudson, N.R.; Torres, S.; Harrach, B.; Seto, D.; Chodosh, J.; Jones, M.S. Genomic characterization of human adenovirus 36, a putative obesity agent. Virus Res. 2010, 149, 152–161.
41. Gregoire, F.M.; Smas, C.M.; Sul, H.S. Understanding adipocyte differentiation. Physiol. Rev. 1998, 78, 783–809.
42. Rogers, P.M.; Fusinski, K.A.; Rathod, M.A.; Loiler, S.A.; Pasarica, M.; Shaw, M.K.; Kilroy, G.; Sutton, G.M.; McAllister, E.J.; Mashtalir, N.; et al. Human adenovirus ad-36 induces adipogenesis via its e4 orf-1 gene. Int. J. Obes. 2008, 32, 397–406.
43. Vangipuram, S.D.; Yu, M.; Tian, J.; Stanhope, K.L.; Pasarica, M.; Havel, P.J.; Heydari, A.R.; Dhurandhar, N.V. Adipogenic human adenovirus-36 reduces leptin expression and secretion and increases glucose uptake by fat cells. Int. J. Obes. 2007, 31, 87–96.
44. Pasarica, M.; Mashtalir, N.; McAllister, E.J.; Kilroy, G.E.; Koska, J.; Permana, P.; de Courten, B.; Yu, M.; Ravussin, E.; Gimble, J.M.; et al. Adipogenic human adenovirus ad-36 induces commitment, differentiation, and lipid accumulation in human adipose-derived stem cells. Stem Cells 2008, 26, 969–978.
45. Wang, Z.Q.; Yu, Y.; Zhang, X.H.; Floyd, E.Z.; Cefalu, W.T. Human adenovirus 36 decreases fatty acid oxidation and increases de novo lipogenesis in primary cultured human skeletal muscle cells by promoting cidec/fsp27 expression. Int. J. Obes. 2010, 34, 1355–1364.
46. Nam, J.H. Why is not there a match between the serological and genomic prevalence of adenovirus 36? J. Clin. Virol. 2013, 56, 370–371.
47. Nam, J.H.; Na, H.N.; Atkinson, R.L.; Dhurandhar, N.V. Genomic stability of adipogenic human adenovirus 36. Int. J. Obes. 2014, 38, 321–324.
48. Salehian, B.; Forman, S.J.; Kandeel, F.R.; Bruner, D.E.; He, J.; Atkinson, R.L. Adenovirus 36 DNA in adipose tissue of patient with unusual visceral obesity. Emerg. Infect. Dis. 2010, 16, 850–852.
49. Atkinson, R.L.; Dhurandhar, N.V.; Allison, D.B.; Bowen, R.L.; Israel, B.A.; Albu, J.B.; Augustus, A.S. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int. J. Obes. 2005, 29, 281–286.
50. Broderick, M.P.; Hansen, C.J.; Irvine, M.; Metzgar, D.; Campbell, K.; Baker, C.; Russell, K.L. Adenovirus 36 seropositivity is strongly associated with race and gender, but not obesity, among us military personnel. Int. J. Obes. 2010, 34, 302–308.
51. Goossens, V.J.; deJager, S.A.; Grauls, G.E.; Gielen, M.; Vlietinck, R.F.; Derom, C.A.; Loos, R.J.; Rensen, S.S.; Buurman, W.A.; Greve, J.W.; et al. Lack of evidence for the role of human adenovirus-36 in obesity in a european cohort. Obesity 2011, 19, 220–221.
52. Bil-Lula, I.; Plonek, T.; Wozniak, M. Lack of adenovirus DNA in mediastinal adipose tissue of obese/overweight adults with cardiovascular disorders? J. Med. Virol. 2014, 86, 802–805.
53. Na, H.N.; Hong, Y.M.; Kim, J.; Kim, H.K.; Jo, I.; Nam, J.H. Association between human adenovirus-36 and lipid disorders in korean schoolchildren. Int. J. Obes. 2010, 34, 89–93.
54. Almgren, M.; Atkinson, R.; He, J.; Hilding, A.; Hagman, E.; Wolk, A.; Thorell, A.; Marcus, C.; Naslund, E.; Ostenson, C.G.; et al. Adenovirus-36 is associated with obesity in children and adults in sweden as determined by rapid elisa. PLoS ONE 2012, 7, e41652.
55. Aldhoon-Hainerova, I.; Zamrazilova, H.; Atkinson, R.L.; Dusatkova, L.; Sedlackova, B.; Hlavaty, P.; Lee, Z.P.; Kunesova, M.; Hainer, V. Clinical and laboratory characteristics of 1179 czech adolescents evaluated for antibodies to human adenovirus 36. Int. J. Obes. 2014, 38, 285–291.
56. Atkinson, R.L.; Lee, I.; Shin, H.J.; He, J. Human adenovirus-36 antibody status is associated with obesity in children. Int. J. Pediatr. Obes. 2010, 5, 157–160.
57. Cakmakliogullari, E.K.; Sanlidag, T.; Ersoy, B.; Akcali, S.; Var, A.; Cicek, C. Are human adenovirus-5 and 36 associated with obesity in children? J. Investig. Med. 2014, 62, 821–824.
58. Gabbert, C.; Donohue, M.; Arnold, J.; Schwimmer, J.B. Adenovirus 36 and obesity in children and adolescents. Pediatrics 2010, 126, 721–726.
59. Parra-Rojas, I.; del Moral-Hernandez, O.; Salgado-Bernabe, A.B.; Guzman-Guzman, I.P.; Salgado-Goytia, L.; Munoz-Valle, J.F. Adenovirus-36 seropositivity and its relation with obesity and metabolic profile in children. Int. J. Endocrinol. 2013, 2013, e463194.
60. Tosh, A.K.; Broy-Aschenbrenner, A.; El Khatib, J.; Ge, B. Adenovirus-36 antibody status & bmi comparison among obese missouri adolescents. Mo. Med. 2012, 109, 402–403.
61. Vander Wal, J.S.; Huelsing, J.; Dubuisson, O.; Dhurandhar, N.V. An observational study of the association between adenovirus 36 antibody status and weight loss among youth. Obes. Facts 2013, 6, 269–278.
62. Yamada, T.; Hara, K.; Kadowaki, T. Association of adenovirus 36 infection with obesity and metabolic markers in humans: A meta-analysis of observational studies. PLoS ONE 2012, 7, e42031.
63. Shang, Q.; Wang, H.; Song, Y.; Wei, L.; Lavebratt, C.; Zhang, F.; Gu, H. Serological data analyses show that adenovirus 36 infection is associated with obesity: A meta-analysis involving 5739 subjects. Obesity 2014, 22, 895–900.
64. 64. Wang, Z.Q.; Cefalu, W.T.; Zhang, X.H.; Yu, Y.; Qin, J.; Son, L.; Rogers, P.M.; Mashtalir, N.;Bordelon, J.R.; Ye, J.; et al. Human adenovirus type 36 enhances glucose uptake in diabetic and nondiabetic human skeletal muscle cells independent of insulin signaling. Diabetes 2008, 57, 1805–1813.
65. Krishnapuram, R.; Dhurandhar, E.J.; Dubuisson, O.; Hegde, V.; Dhurandhar, N.V. Doxycycline-regulated 3t3-l1 preadipocyte cell line with inducible, stable expression of adenoviral e4orf1 gene: A cell model to study insulin-independent glucose disposal. PLoS ONE 2013, 8, e60651.
66. Dhurandhar, E.J.; Krishnapuram, R.; Hegde, V.; Dubuisson, O.; Tao, R.; Dong, X.C.; Ye, J.; Dhurandhar, N.V. E4orf1 improves lipid and glucose metabolism in hepatocytes: A template to improve steatosis & hyperglycemia. PLoS ONE 2012, 7, e47813.
67. Lynch, L.A.; O’Connell, J.M.; Kwasnik, A.K.; Cawood, T.J.; O’Farrelly, C.; O’Shea, D.B. Are natural killer cells protecting the metabolically healthy obese patient? Obesity 2009, 17, 601–605.
68. Yang, H.; Youm, Y.H.; Vandanmagsar, B.; Rood, J.; Kumar, K.G.; Butler, A.A.; Dixit, V.D. Obesity accelerates thymic aging. Blood 2009, 114, 3803–3812.
69. Nieman, D.C.; Nehlsen-Cannarella, S.I.; Henson, D.A.; Butterworth, D.E.; Fagoaga, O.R.; Warren, B.J.; Rainwater, M.K. Immune response to obesity and moderate weight loss. Int. J. Obes. Relat. Metab. Disord. 1996, 20, 353–360.
70. O’Rourke, R.W.; Kay, T.; Scholz, M.H.; Diggs, B.; Jobe, B.A.; Lewinsohn, D.M.; Bakke, A.C. Alterations in T-cell subset frequency in peripheral blood in obesity. Obes. Surg. 2005, 15, 1463–1468.
71. O’Shea, D.; Corrigan, M.; Dunne, M.R.; Jackson, R.; Woods, C.; Gaoatswe, G.; Moynagh, P.N.; O’Connell, J.; Hogan, A.E. Changes in human dendritic cell number and function in severe obesity may contribute to increased susceptibility to viral infection. Int. J. Obes. 2013, 37, 1510–1513.
72. Na, H.N.; Nam, J.H. Adenovirus 36 as an obesity agent maintains the obesity state by increasing mcp-1 and inducing inflammation. J. Infect. Dis. 2012, 205, 914–922.
73. Stienstra, R.; Duval, C.; Muller, M.; Kersten, S. Ppars, obesity, and inflammation. PPAR Res. 2007, 2007, e95974.
74. Tordjman, J.; Guerre-Millo, M.; Clement, K. Adipose tissue inflammation and liver pathology in human obesity. Diabetes Metab. 2008, 34, 658–663.
75. Bastard, J.P.; Maachi, M.; Lagathu, C.; Kim, M.J.; Caron, M.; Vidal, H.; Capeau, J.; Feve, B. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur. Cytokine Netw. 2006, 17, 4–12.
76. Vendrell, J.; Broch, M.; Vilarrasa, N.; Molina, A.; Gomez, J.M.; Gutierrez, C.; Simon, I.; Soler, J.; Richart, C. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: Relationships in obesity. Obes. Res. 2004, 12, 962–971.
77. Na, H.N.; Kim, H.; Nam, J.H. Novel genes and cellular pathways related to infection with adenovirus-36 as an obesity agent in human mesenchymal stem cells. Int. J. Obes. 2012, 36, 195–200.
78. Kanda, H.; Tateya, S.; Tamori, Y.; Kotani, K.; Hiasa, K.; Kitazawa, R.; Kitazawa, S.; Miyachi, H.; Maeda, S.; Egashira, K.; et al. Mcp-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Investig. 2006, 116, 1494–1505.
79. Kirk, E.A.; Sagawa, Z.K.; McDonald, T.O.; O’Brien, K.D.; Heinecke, J.W. Monocyte chemoattractant protein deficiency fails to restrain macrophage infiltration into adipose tissue [corrected]. Diabetes 2008, 57, 1254–1261.
80. Fujisaka, S.; Usui, I.; Bukhari, A.; Ikutani, M.; Oya, T.; Kanatani, Y.; Tsuneyama, K.; Nagai, Y.; Takatsu, K.; Urakaze, M.; et al. Regulatory mechanisms for adipose tissue m1 and m2 macrophages in diet-induced obese mice. Diabetes 2009, 58, 2574–2582.
81. Aron-Wisnewsky, J.; Tordjman, J.; Poitou, C.; Darakhshan, F.; Hugol, D.; Basdevant, A.; Aissat, A.; Guerre-Millo, M.; Clement, K. Human adipose tissue macrophages: M1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss. J. Clin. Endocrinol. Metab. 2009, 94, 4619–4623.
82. Lumeng, C.N.; Bodzin, J.L.; Saltiel, A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Investig. 2007, 117, 175–184.
83. Wozniak, S.E.; Gee, L.L.; Wachtel, M.S.; Frezza, E.E. Adipose tissue: The new endocrine organ? A review article. Dig. Dis. Sci. 2009, 54, 1847–1856.
84. Axelsson, J.; Heimburger, O.; Lindholm, B.; Stenvinkel, P. Adipose tissue and its relation to inflammation: The role of adipokines. J. Ren. Nutr. 2005, 15, 131–136.
85. Bluher, M. Adipose tissue dysfunction in obesity. Exp. Clin. Endocrinol. Diabetes 2009, 117, 241–250.
86. Gale, S.M.; Castracane, V.D.; Mantzoros, C.S. Energy homeostasis, obesity and eating disorders: Recent advances in endocrinology. J. Nutr. 2004, 134, 295–298.
87. 87 . Mancuso, P. Obesity and respiratory infections: Does excess adiposity weigh down host defense? Pulm. Pharmacol. Ther. 2013, 26, 412–419.
88. Myers, M.G.; Cowley, M.A.; Munzberg, H. Mechanisms of leptin action and leptin resistance. Annu. Rev. Physiol. 2008, 70, 537–556.
89. Morrison, C.D. Leptin resistance and the response to positive energy balance. Physiol. Behav. 2008, 94, 660–663.
90. Martin-Romero, C.; Santos-Alvarez, J.; Goberna, R.; Sanchez-Margalet, V. Human leptin enhances activation and proliferation of human circulating t lymphocytes. Cell. Immunol. 2000, 199, 15–24.
91. Iikuni, N.; Lam, Q.L.; Lu, L.; Matarese, G.; La Cava, A. Leptin and inflammation. Curr. Immunol. Rev. 2008, 4, 70–79.
92. Kohm, A.P.; Sanders, V.M. Norepinephrine and beta 2-adrenergic receptor stimulation regulate cd4+ t and b lymphocyte function in vitro and in vivo. Pharmacol. Rev. 2001, 53, 487–525.
93. Na, H.N.; Nam, J.H. Proof-of-concept for a virus-induced obesity vaccine; vaccination against the obesity agent adenovirus 36. Int. J. Obes. 2014, 38, 1470–1474.
94. 94 . Na, H.N.; Kim, H.; Nam, J.H. Prophylactic and therapeutic vaccines for obesity. Clin. Exp. Vaccine Res. 2014, 3, 37–41.
95. Trovato, G.M.; Castro, A.; Tonzuso, A.; Garozzo, A.; Martines, G.F.; Pirri, C.; Trovato, F.; Catalano, D. Human obesity relationship with ad36 adenovirus and insulin resistance. Int. J. Obes. 2009, 33, 1402–1409.
96. Trovato, G.M.; Martines, G.F.; Garozzo, A.; Tonzuso, A.; Timpanaro, R.; Pirri, C.; Trovato, F.M.; Catalano, D. Ad36 adipogenic adenovirus in human non-alcoholic fatty liver disease. Liver Int. 2010, 30, 184–190.
97. Krishnapuram, R.; Dhurandhar, E.J.; Dubuisson, O.; Kirk-Ballard, H.; Bajpeyi, S.; Butte, N.; Sothern, M.S.; Larsen-Meyer, E.; Chalew, S.; Bennett, B.; et al. Template to improve glycemic control without reducing adiposity or dietary fat. Am. J. Physiol. Endocrinol. Metab. 2011, 300, E779–E789.
98. Na, H.N.; Kim, J.; Lee, H.S.; Shim, K.W.; Kimm, H.; Jee, S.H.; Jo, I.; Nam, J.H. Association of human adenovirus-36 in overweight korean adults. Int. J. Obes. 2012, 36, 281–285.
99. Trovato, G.M.; Martines, G.F.; Trovato, F.M.; Pirri, C.; Pace, P.; Garozzo, A.; Castro, A.; Catalano, D. Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance. Dig. Dis. Sci. 2012, 57, 535–544.
100. Lin, W.Y.; Dubuisson, O.; Rubicz, R.; Liu, N.; Allison, D.B.; Curran, J.E.; Comuzzie, A.G.; Blangero, J.; Leach, C.T.; Goring, H.; et al. Long-term changes in adiposity and glycemic control are associated with past adenovirus infection. Diabetes Care 2013, 36, 701–707.
101. Laing, E.M.; Tripp, R.A.; Pollock, N.K.; Baile, C.A.; Della-Fera, M.A.; Rayalam, S.; Tompkins, S.M.; Keys, D.A.; Lewis, R.D. Adenovirus 36, adiposity, and bone strength in late-adolescent females. J. Bone Miner. Res. 2013, 28, 489–496.
102. Berger, P.K.; Pollock, N.K.; Laing, E.M.; Warden, S.J.; Hill Gallant, K.M.; Hausman, D.B.; Tripp, R.A.; McCabe, L.D.; McCabe, G.P.; Weaver, C.M.; et al. Association of adenovirus 36 infection with adiposity and inflammatory-related markers in children. J. Clin. Endocrinol. Metab. 2014, 99, 3240–3246.
103. Voss, J.D.; Burnett, D.G.; Olsen, C.H.; Haverkos, H.W.; Atkinson, R.L. Adenovirus 36 antibodies associated with clinical diagnosis of overweight/obesity but not bmi gain: A military cohort study. J. Clin. Endocrinol. Metab. 2014, 99, E1708–E1712.
104. Karamese, M.; Altoparlak, U.; Turgut, A.; Aydogdu, S.; Karamese, S.A. The relationship between adenovirus-36 seropositivity, obesity and metabolic profile in turkish children and adults. Epidemiol. Infect. 2015, 16, 1–7.
105. Ergin, S.; Altan, E.; Pilanci, O.; Sirekbasan, S.; Cortuk, O.; Cizmecigil, U.; Ersin, I.; Elbey, H.; Dinc, H.O.; Habip, Z.; et al. The role of adenovirus 36 as a risk factor in obesity: The first clinical study made in the fatty tissues of adults in turkey. Microb. Pathog. 2015, 80, 57–62.